QR-Code

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter

Aim. To compare the efficacy and safety of chemical cardioversion (CCV) with refralon and amiodarone in patients with paroxysmal atrial fibril­lation and flutter (AF/AFL).Material and methods. Fifty five patients (mean age, 65±11 years) with paroxysmal AF/AFL were included. All patients underwent a...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: D. A. Gagloeva, Kh. M. Dzaurova, M. A. Zelberg, N. Yu. Mironov, Yu. A. Yuricheva, S. F. Sokolov, M. A. Krymukova, A. I. Salpagarova, L. O. Dulaev, D. V. Pevzner, S. P. Golitsyn
Format: Artigo
Sprache:Russo
Veröffentlicht: «SILICEA-POLIGRAF» LLC 2023-05-01
Schriftenreihe:Кардиоваскулярная терапия и профилактика
Schlagworte:
atrial fibrillation
paroxysmal type
refralon
amiodarone
chemical cardioversion
class iii antiarrhythmic drugs
Online-Zugang:https://cardiovascular.elpub.ru/jour/article/view/3527
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge